US News

Pfizer begins testing use of pneumococcal vaccine along with COVID-19 booster shot

Published by

(Corrects spelling of pneumococcal in headline) (Reuters) – Pfizer Inc said on Monday it has started immunizing the first patients in a new study looking at administering the company’s 20-valent pneumococcal conjugate vaccine candidate following a booster dose of the Pfizer-BioNTech COVID-19 shot. The study will include 600 adults over 65 years who will be recruited from the late-stage study of the Pfizer-BioNTech COVID-19 vaccine, and will have received their second dose of the vaccine at least six months prior to entering the co-administration study, the company said. (This story has been re…

Read More

Facebook Comments

Check Also

Treasury’s Yellen urges Congress to raise US debt limit

Published by AFP Washington (AFP) – US Treasury ...